GPR88 as a novel target for fronto-striatal dysfunction in schizophrenia

Langmead, Christopher (Primary Chief Investigator (PCI))
Nithianantharajah, Jess (Chief Investigator (CI))

Faculty of Pharmacy and Pharmaceutical Sciences

Project: Research

Status	Finished
Effective start/end date	1/01/16 → 31/12/18

Funding

National Health and Medical Research Council (NHMRC) (Australia): A$303,483.00
National Health and Medical Research Council (NHMRC) (Australia): A$303,483.00

1 Article

Gpr88 Deletion Impacts Motivational Control Without Overt Disruptions to Striatal Dopamine
Spark, D. L., Vermeulen, M. H., de la Fuente Gonzalez, R. A., Hatzipantelis, C. J., Rueda, P., Sepehrizadeh, T., De Veer, M., Mannoury la Cour, C., Fornito, A., Langiu, M., Stewart, G. D., Nithianantharajah, J. & Langmead, C. J., Oct 2023, In: Biological Psychiatry: Global Open Science. 3, 4, p. 1053-1061 9 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

1 Citation (Scopus)